Managers / Q1 2023 · view latest →
Value Star Asset Management (Hong Kong) Ltd
CIK 0001842246 · ROOM 2706, 27/F, THE CENTRIUM,, 60 WYNDHAM STREET, CENTRAL,, HONG KONG, K3, 0000 · 852-21850800
Summary
Value Star Asset Management (Hong Kong) Ltd reported $256M in U.S.-listed holdings across 24 positions for Q1 2023.
Its largest position, MSFT, represents 18.4% of the portfolio.
Compared with Q4 2022, the fund opened 6 new positions and exited 10.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 89.4% · $229M
- ADR · 7.2% · $18M
- Other · 3.4% · $9M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AMDADVANCED MICRO DEVICES | NEW | +260.0K | 260.0K | +$25M | $25M |
| TSMTAIWAN SEMICONDUCTOR-SP | NEW | +54.0K | 54.0K | +$5M | $5M |
| METAMETA PLATFORMS INC | NEW | +22.0K | 22.0K | +$5M | $5M |
| MAXEON SOLAR TECHNOLOGIE | NEW | +49.0K | 49.0K | +$1M | $1M |
| CRISPR THERAPEUTICS AG | NEW | +12.8K | 12.8K | +$581,205 | $581,205 |
| NTLAINTELLIA THERAPEUTICS INC | NEW | +14.8K | 14.8K | +$549,732 | $549,732 |
| LULULULULEMON ATH | ADDED | +17.8K | 19.8K | +$7M | $7M |
| UBERUBER TECHNOLOGIES INC | ADDED | +348.9K | 408.9K | +$11M | $13M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $49M | 11 | Oct 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $32M | 10 | Jul 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $16M | 10 | Apr 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $32M | 13 | Feb 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $27M | 9 | Oct 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $270M | 18 | Jul 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $290M | 22 | May 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $292M | 21 | Feb 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $284M | 23 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $338M | 29 | Aug 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $256M | 24 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 28 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $171.7B | 32 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $136.8B | 29 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $176.3B | 27 | Apr 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $199.1B | 30 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $152.8B | 21 | Nov 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | Under review | 25 | Aug 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $137M | 19 | Apr 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $110M | 19 | Jan 27, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.